New nanotechnology drug to control blindness

The Mexican company “Medical and Surgical Center for Retina” has created a way to deliver drugs in order to avoid risks and painful treatments in people with secondary blindness due to chronic degenerative blindness such as diabetic retinopathy and degeneration of the eye. The innovative formula eliminates the need to administrate drugs by intraocular injection.

It is a nanotechnology product, which works with last-generation liposome particles concentrated in droplets, which function as a conveyor that wraps proteins or antibody fragments and allows its passage into the eye. Once inside, it releases the drugs.

The nanotechnology product reduces costs by 80 to 90 percent and is ideal for the elderly population. “With this technology, hospitals that have no resources can administer the prescribed drugs without requiring a a specialist or a particular facility. A physician’s prescription is necessary, but it can be administered at home, which lowers the cost. “
Dr. Juan Carlos Altamirano Vallejo, medical director of the Medical and Surgical Center for Retina, says that the conditions that originate in the retina are mostly caused by chronic degenerative diseases such as diabetes (diabetic retinopathy) or macular degeneration. Patients with these conditions usually require one injection per month, which comes at a very high cost that increases if the procedure is needed for both eyes.
The company, located in Jalisco (central west state of Mexico) won the Mexican National Prize for Technology and Innovation and plans to conclude the Clinical Research regulated by the Federal Commission for Protection Against Health Risks (COFEPRIS) next year. The idea is for the medicine to be distributed in state and private health institutions. So far, the achieved results are the same as the ones obtained with intraocular injection, but without the inherent risks of this procedure, such as infection or retinal detachment……..
Read more:
Source: Medical Xpress